Logo Rosalind & Morris Goodman Cancer Institute
. . .
. .
 
 
  • Home
  • Research
  • Principal Investigators

  • Heather Melichar

Ph.D.

  • T cells
  • Cancer immunotherapy
  • Autoimmunity

More

  • Peter Siegel

Ph.D.

  • Metastasis
  • Metabolism
  • Tumour Microenvironment

More

  • Vincent Giguere

Ph.D., F.R.S.C.

  • Breast cancer
  • Prostate cancer
  • Fatty liver diseases

More

  • Jose Teodoro

Ph.D.

  • Tumor angiogenesis
  • Apoptosis and cancer
  • Cell signaling and cancer

More

  • Alain Nepveu

Ph.D.

  • Transcriptional control
  • DNA damage response and repair pathways
  • Drug sensitivity and resistance

More

  • Lawrence Kazak

Ph.D.

  • Metabolite signaling
  • Energy balance
  • Metabolic diseases

More

  • Arnim Pause

Ph.D.

  • Cancer energy pathways
  • MiTF/TFE3 transcription factors
  • FLCN

More

  • William Muller

Ph.D., F.R.S.C.

  • Breast Cancer
  • Lung Metastasis
  • Tumour Immune Microenvironment

More

  • Xiang-Jiao Yang

Ph.D.

  • Molecular and epigenetic basis of cancer
  • Stem cells
  • Animal development

More

  • Josée Dostie

Ph.D.

  • 3D genome architecture
  • Epigenetics
  • Gene expression

More

  • Philippe Gros

Ph.D.

  • Genetic susceptibility to disease
  • Innate immunity
  • Chemotherapy resistance

More

  • Logan Walsh

Ph.D.

  • Cancer genetics
  • Single cell spatial technologies
  • Tumor microenvironment

More

  • Katie Cockburn

Ph.D.

  • Epidermal stem cells
  • Cell communication
  • Intravital imaging

More

  • Nahum Sonenberg

Ph.D., F.R.S.C.

  • Mechanisms of mRNA translation initiation
  • Translational Control in Viral Infection, Cancer, Memory and Neurodegenerative Diseases

More

  • Luke McCaffrey

Ph.D.

  • Epithelial morphogenesis
  • Cell polarity
  • Early cancer progression

More

  • George Zogopoulos

M.D., Ph.D.

  • Pancreatic Cancer
  • Cancer Genetics
  • Translational Research

More

  • Thomas Duchaine

Ph.D.

  • RNA interference (RNAi) pathways
  • RNA-binding proteins
  • Control of gene expression

More

  • Michel Tremblay

Ph.D.

  • Protein tyrosine phosphatases
  • Cellular signaling
  • Immunotherapy

More

  • Ian Watson

Ph.D.

  • Melanoma Translational Research
  • Cancer Cell Signaling
  • Multiomic Approaches

More

  • Yojiro Yamanaka

Ph.D.

  • Ovarian cancer
  • Evolution
  • The female reproductive tract

More

  • Morag Park

Ph.D.

  • Receptor tyrosine kinase and proto-oncogene MET 
  • Breast cancer and tumour microenvironment

More

  • Guojun Chen

Ph.D.

  • Drug delivery
  • Gene delivery
  • Cancer therapy

More

  • Daniela Quail

Ph.D.

  • Cancer
  • Tumor immunology
  • Tumor microenvironment

More

  • Hannah Garner

Ph.D.

  • Chronic inflammation
  • Myeloid cell biology
  • Breast and ovarian cancers

More

  • Sidong Huang

Ph.D.

  • Functional genomics
  • Therapy resistance
  • Hard-to-treat cancers

More

Discover our
research themes

Rosalind & Morris Goodman Cancer Institute - The knowledge to cure

Newsletter

Subscribe

Take a stand

Give today

News • Contact us • Newsroom • Login

The Institute About us History Our Legacy Team Annual reports EDI Green Initiative

Research Our research Principal Investigators Recent publications

Trainees The experience Programs Student Society Internal funding

Career Working with us

Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte

Support our mission
Powered by Yapla Logo